Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

[Possibility of achieving and maintaining asthma control in patients with bronchial cold hyperreactivity].

Kolosov VP, Pirogov AB, Perel'man IuM, Mal'tseva TA, Prikhod'ko AG.

Ter Arkh. 2014;86(3):40-4. Russian.

PMID:
24779069
3.

Comparison of anti-inflammatory and clinical effects of beclomethasone dipropionate and salmeterol in moderate asthma.

Bacci E, Di Franco A, Bartoli ML, Carnevali S, Cianchetti S, Dente FL, Giannini D, Vagaggini B, Ruocco L, Paggiaro PL.

Eur Respir J. 2002 Jul;20(1):66-72.

4.
5.
6.

Effect of inhaled beclomethasone dipropionate and budesonide dry powder on pulmonary function and serum eosinophil cationic protein in adult asthmatics.

Dal Negro R, Micheletto C, Tognella S, Mauroner L, Burti E, Turco P, Pomari C, Cantini L.

J Investig Allergol Clin Immunol. 1999 Jul-Aug;9(4):241-7.

PMID:
10513351
7.

Benefits of induced sputum for the evaluation of therapeutic efficacy in patients with bronchial asthma.

Ohnishi H, Maeda H, Nishimura Y, Yokoyama M.

Kobe J Med Sci. 1998 Aug;44(4):149-61.

PMID:
10352494
8.

Effect of salmeterol compared with beclomethasone on allergen-induced asthmatic and inflammatory responses.

Pizzichini MM, Kidney JC, Wong BJ, Morris MM, Efthimiadis A, Dolovich J, Hargreave FE.

Eur Respir J. 1996 Mar;9(3):449-55. Erratum in: Eur Respir J 1996 Oct;9(10):2190.

10.

Exhaled NO and assessment of anti-inflammatory effects of inhaled steroid: dose-response relationship.

Jones SL, Herbison P, Cowan JO, Flannery EM, Hancox RJ, McLachlan CR, Taylor DR.

Eur Respir J. 2002 Sep;20(3):601-8.

11.

Lung function and asthma control with beclomethasone and formoterol in a single inhaler.

Huchon G, Magnussen H, Chuchalin A, Dymek L, Gonod FB, Bousquet J.

Respir Med. 2009 Jan;103(1):41-9. doi: 10.1016/j.rmed.2008.09.002. Epub 2008 Nov 1.

12.

Salmeterol decreases eosinophilic cationic protein and rescue medication in patients inhaling beclomethasone dipropionate: preliminary study in mild and moderate asthma in Trinidad, West Indies.

Pinto Pereira LM, Clement Y, Rouse J, Matthew J, Asgarali Z, Ramoutar D, Teelucksingh S.

Int J Clin Pharmacol Res. 2003;23(2-3):69-74.

PMID:
15025036
13.
15.
16.

Bronchial hyper-responsiveness predicts the development of mild clinical asthma within 2 yr in school children with hay-fever.

Ferdousi HA, Zetterström O, Dreborg S.

Pediatr Allergy Immunol. 2005 Sep;16(6):478-86.

PMID:
16176394
17.

The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics.

Solèr M, Matz J, Townley R, Buhl R, O'Brien J, Fox H, Thirlwell J, Gupta N, Della Cioppa G.

Eur Respir J. 2001 Aug;18(2):254-61. Erratum in: Eur Respir J 2001 Oct;18(4):739-40.

18.

A randomized, double-blind comparison of beclomethasone dipropionate extrafine aerosol and fluticasone propionate.

Fairfax A, Hall I, Spelman R.

Ann Allergy Asthma Immunol. 2001 May;86(5):575-82.

PMID:
11379810
19.

[Effect of inhalation therapy with beclomethasone dipropionate on unspecific bronchial hyperreactivity in patients with asthma].

Jahnz-Rózyk K, Frank-Piskorska A, Kozak E.

Pol Tyg Lek. 1991 May 27-Jun 3;46(22-23):403-5. Polish.

PMID:
1669074

Supplemental Content

Support Center